Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intestinal hormones and growth factors: effects on the small intestine.

Literature DB >> 19152442

Intestinal hormones and growth factors: effects on the small intestine.

Abstract

There are various hormones and growth factors which may modify the intestinal absorption of nutrients, and which might thereby be useful in a therapeutic setting, such as in persons with short bowel syndrome. In part I, we focus first on insulin-like growth factors, epidermal and transferring growth factors, thyroid hormones and glucocorticosteroids. Part II will detail the effects of glucagon-like peptide (GLP)-2 on intestinal absorption and adaptation, and the potential for an additive effect of GLP2 plus steroids.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2009 PMID： 19152442 PMCID： PMC2653359 DOI： 10.3748/wjg.15.385

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

281 in total

1. Antenatal dexamethasone and decreased birth weight.

Authors: S L Bloom; J S Sheffield; D D McIntire; K J Leveno
Journal: Obstet Gynecol Date: 2001-04 Impact factor: 7.661

2. Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract.

Authors: D M Thomas; M M Nasim; W J Gullick; M R Alison
Journal: Gut Date: 1992-05 Impact factor: 23.059

3. Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

Authors: J J Smith; R Derynck; M Korc
Journal: Proc Natl Acad Sci U S A Date: 1987-11 Impact factor: 11.205

4. Prevention of dexamethasone-induced lymphocytic apoptosis in the intestine and in Peyer patches by enteral nutrition.

Authors: S Ruiz-Santana; A López; S Torres; A Rey; A Losada; L Latasa; J L Manzano; B N Díaz-Chico
Journal: JPEN J Parenter Enteral Nutr Date: 2001 Nov-Dec Impact factor: 4.016

5. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2.

Authors: D J Drucker; L DeForest; P L Brubaker
Journal: Am J Physiol Date: 1997-12

6. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I.

Authors: K Ohneda; M H Ulshen; C R Fuller; A J D'Ercole; P K Lund
Journal: Gastroenterology Date: 1997-02 Impact factor: 22.682

7. Production of hepatocyte growth factor from human lung microvascular endothelial cells induced by interleukin-1beta.

Authors: T Morisako; K Takahashi; K Kishi; T Kiguchi; R Mikami; K Kobayashi; H Yagyu; H Nakamura; K T Matsuoka
Journal: Exp Lung Res Date: 2001-12 Impact factor: 2.459

8. Glucagon-like peptide-2: divergent signaling pathways.

Authors: Flavio G Rocha; K Robert Shen; Jasleen Jasleen; Ali Tavakkolizadeh; Michael J Zinner; Edward E Whang; Stanley W Ashley
Journal: J Surg Res Date: 2004-09 Impact factor: 2.192

9. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.

Authors: E Caldenhoven; J Liden; S Wissink; A Van de Stolpe; J Raaijmakers; L Koenderman; S Okret; J A Gustafsson; P T Van der Saag
Journal: Mol Endocrinol Date: 1995-04

10. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.

Authors: Chhanda Bose; Kodetthoor B Udupa
Journal: Am J Physiol Cell Physiol Date: 2008-06-11 Impact factor: 4.249

24 in total

1. Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection.

Authors: Meredith C Hitch; Jennifer A Leinicke; Derek Wakeman; Jun Guo; Chris R Erwin; Kathryn J Rowland; Ellen C Merrick; Robert O Heuckeroth; Brad W Warner
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-03-15 Impact factor: 4.052

Review 2. Recent advances in small bowel diseases: Part II.

Authors: Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal: World J Gastroenterol Date: 2012-07-14 Impact factor: 5.742

3. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.

Authors: Taisuke Sakanaka; Takuya Inoue; Naoki Yorifuji; Munetaka Iguchi; Kaori Fujiwara; Ken Narabayashi; Kazuki Kakimoto; Sadaharu Nouda; Toshihiko Okada; Takanori Kuramoto; Kumi Ishida; Yosuke Abe; Toshihisa Takeuchi; Eiji Umegaki; Yasutada Akiba; Jonathan D Kaunitz; Kazuhide Higuchi
Journal: J Gastroenterol Hepatol Date: 2015-03 Impact factor: 4.029

4. Loss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival.

Authors: Georg Mellitzer; Anthony Beucher; Viviane Lobstein; Pascal Michel; Sylvie Robine; Michèle Kedinger; Gérard Gradwohl
Journal: J Clin Invest Date: 2010-04-01 Impact factor: 14.808

Review 5. Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors.

Authors: Sarah F Bortvedt; P Kay Lund
Journal: Curr Opin Gastroenterol Date: 2012-03 Impact factor: 3.287

6. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, suppresses CXCL5 and SDF-1 and does not accelerate intestinal neoplasia formation in Apc^Min/+ mice fed a high-fat diet.

Authors: Kaori Fujiwara; Takuya Inoue; Yujiro Henmi; Yoshimasa Hirata; Yutaka Naka; Azusa Hara; Kazuki Kakimoto; Sadaharu Nouda; Toshihiko Okada; Ken Kawakami; Toshihisa Takeuchi; Kazuhide Higuchi
Journal: Oncol Lett Date: 2017-08-01 Impact factor: 2.967

7. Carboxypeptidase O is a glycosylphosphatidylinositol-anchored intestinal peptidase with acidic amino acid specificity.

Authors: Peter J Lyons; Lloyd D Fricker
Journal: J Biol Chem Date: 2011-09-15 Impact factor: 5.157